U.S. Healthcare Services Stock News

Key Insights Automatic Data Processing's Annual General Meeting to take place on 12th of November CEO Maria Black's...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Upland Software, Inc.'s (NASDAQ:UPLD) stock price has dropped 10% in the previous week, but insiders who sold US$84k in...

While Tecnoglass Inc. ( NYSE:TGLS ) might not have the largest market cap around , it saw significant share price...

It is hard to get excited after looking at Lovesac's (NASDAQ:LOVE) recent performance, when its stock has declined 25...

Insiders who bought OptimizeRx Corporation ( NASDAQ:OPRX ) in the last 12 months may probably not pay attention to the...

Readers hoping to buy Pitney Bowes Inc. ( NYSE:PBI ) for its dividend will need to make their move shortly, as the...

Most readers would already be aware that Coda Octopus Group's (NASDAQ:CODA) stock increased significantly by 23% over...

We wouldn't blame Dorman Products, Inc. ( NASDAQ:DORM ) shareholders if they were a little worried about the fact that...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...

Rave Restaurant Group, Inc. ( NASDAQ:RAVE ) shareholders won't be pleased to see that the share price has had a very...

The SOLAI Limited ( NYSE:SLAI ) share price has fared very poorly over the last month, falling by a substantial 30...

Key Insights The projected fair value for Cerence is US$9.34 based on 2 Stage Free Cash Flow to Equity Cerence's...

When we're researching a company, it's sometimes hard to find the warning signs, but there are some financial metrics...

Knightscope, Inc. ( NASDAQ:KSCP ) shareholders won't be pleased to see that the share price has had a very rough month...

Key Insights The considerable ownership by retail investors in ChargePoint Holdings indicates that they collectively...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Editas Medicine, Inc. ( NASDAQ:EDIT ) shares have retraced a considerable 29% in the last month, reversing a fair...

Key Insights JBS' significant private companies ownership suggests that the key decisions are influenced by...

Premier (PINC) reported a net profit margin of just 0.7% this quarter, a sharp drop from last year’s 11.2%, with earnings having declined at an average annual rate of -25.5% over the past five years. Despite recent pressures, the company is now profitable and is forecasting a robust 32.6% annual earnings growth over the next three years, which is double the 16% expected for the US market overall. These mixed results, combined with a one-off $162.9 million loss, have pushed Premier’s shares to...

On November 3, 2025, Prelude Therapeutics announced a private placement, raising US$25,000,000 by issuing 6,250,000 shares at US$4 each, with participation from Incyte Corporation. Institutional interest from a company like Incyte can be viewed as an endorsement of Prelude’s research direction and funding outlook. We’ll explore how Incyte’s involvement in the private placement shapes Prelude’s investment narrative and financial flexibility. The best AI stocks today may lie beyond giants like...

Wondering if StepStone Group is a hidden gem or getting pricey? You are not alone, and we're here to break down the numbers in plain English. The stock has seen returns of 5.4% year-to-date and 5.9% over the last year, despite minor pullbacks in the last week and month. StepStone's share price has been influenced by recent headlines detailing its continued expansion in private markets and new fund launches, which have caught the eye of both industry watchers and investors. This activity has...

Sequans Communications (SQNS) is currently unprofitable, but has managed to reduce losses by 42.6% per year over the past five years. Revenue is expected to grow 25.61% annually, well ahead of the US market average growth rate of 10.5%. However, the company is still forecast to remain in the red over the next three years. Investors looking at the setup will see attractive top-line growth prospects and a price-to-sales ratio of 2.7x, which is notably lower than the semiconductor industry...